Colorectal Cancer: Epidemiology, Risk Factors, and Prevention.
Roshandel G, Ghasemi-Kebria F, Malekzadeh R. · 2024
Read Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. by Roshandel G, Ghasemi-Kebria F, Malekzadeh R. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11049480.txt.
Introduction
Roshandel, Ghasemi-Kebria, and Malekzadeh review colorectal cancer patterns, risks, and prevention in this 2024 paper. Colorectal cancer grows in the large bowel. In 2020 it caused more than 1.9 million new cases and almost 0.9 million deaths worldwide. It ranks third among cancers for cases and second for deaths.
Rates differ sharply between countries, mainly due to differing risk habits, the authors say. Prevention works on two levels. Primary prevention avoids risks such as alcohol and raises protective habits such as physical activity. Secondary prevention is screening, which finds and removes early growths before they turn cancerous. The review presents the latest evidence on spread, causes, and control programs. Open disputes remain over which factors matter most and which programs work best in each population.
Catalog record
| CREATOR | Roshandel G, Ghasemi-Kebria F, Malekzadeh R. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 99 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Colorectal Cancer: Epidemiology, Risk Factors, and Prevention By Gholamreza Roshandel, Fatemeh Ghasemi-Kebria, Reza Malekzadeh, Antonio V Sterpetti, David A Geller Published in: Cancers DOI: 10.3390/cancers16081530 ABSTRACT Abstract Simple Summary In 2020, more than 1.9 million cases of colorectal cancer (CRC) occurred, and almost 0.9 million patients died due to CRC throughout the world. There are differences in distribution and time variations in CRC between different countries. This diversity is mainly due to differences in risk factors among populations. CRC may be prevented by primary and secondary prevention methods. Primary prevention includes avoiding risk factors, e.g., alcohol consumption, and increasing protective factors, e.g., physical activity. The secondary prevention method, called CRC screening, consists of diagnosis and treatment of precancerous lesions of the colorectum. Although a large amount of evidence is available for different aspects of CRC, controversies remain regarding the most important factors and most effective control programs for CRC in different populations. In this review, we will present the most updated evidence regarding CRC’s distribution, related factors, and preventive methods. Abstract Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer mortality worldwide. There are disparities in the epidemiology of CRC across different populations, most probably due to differences in exposure to lifestyle and environmental factors related to CRC. Prevention is the most effective method for controlling CRC. Primary prevention includes determining and avoiding modifiable risk factors (e.g., alcohol consumption, smoking, and dietary factors) as well as increasing protective factors (e.g., physical activity, aspirin). Further studies, especially randomized, controlled trials, are needed to clarify the association between CRC incidence and exposure to different risk factors or protective factors. Detection and removal of precancerous colorectal lesions is also an effective strategy for controlling CRC. Multiple factors, both at the individual and community levels (e.g., patient preferences, availability of screening modalities, costs, benefits, and adverse events), should be taken into account in designing and implementing CRC screening programs. Health policymakers should consider the best decision in identifying the starting age and selection of the most effective screening strategies for the target population. This review aims to present updated evidence on the epidemiology, risk factors, and prevention of CRC. Keywords: colorectal cancer, epidemiology, risk factors, prevention, screening 1. INTRODUCTION With more than 1.9 million new cases and 0.9 million deaths in 2020, colorectal cancer (CRC) was the third most common cancer and the second most common cause of cancer mortality worldwide [1,2,3]. Geographical disparities were reported in incidence and mortality rates, time trends, and the future burden of CRC across different countries and regions [1,2,3]. There were also changes in the age pattern of CRC, with increasing incidence in the young, especially in developed countries [4]. These disparities may reflect differences in exposure to the risk factors for CRC, including lifestyle and environmental factors [5,6]. Identifying and avoiding modifiable risk factors, especially lifestyle factors (e.g., alcohol consumption, smoking, obesity, unhealthy diet) as well increasing protective factors (e.g., physical activity, taking specific medications such as aspirin, healthy diet) [5,6] have a pivotal role in the primary prevention of CRC. CRC screening (secondary prevention) for the detection and removal of premalignant lesions of the colorectum is also considered an effective preventive method in CRC control programs [7,8,9]. Despite large numbers of studies being conducted on different aspects of CRC, there are still challenges regarding the most important risk factors and most effective preventive strategies for CRC in different populations. An updated, concise review of all of this information may be helpful for researchers, physicians, and policymakers. In this review, we performed a comprehensive search of the latest available literature to present the most updated evidence on the epidemiology, risk factors, and prevention of CRC. 2. EPIDEMIOLOGY 2.1. Mortality According to the GLOBOCAN estimates provided by the International Agency for Research on Cancer (IARC), colorectal cancer (CRC) was the second most common cause of cancer-related death (after lung cancer) worldwide, with an estimated number of 935,173 deaths and an age-standardized mortality rate (ASMR) of 9.0 per 100,000 person-years in 2020. The highest ASMR of CRC was estimated for Europe (12.3), and the lowest one was reported for Africa (5.6) and the eastern Mediterranean region (EMRO) (5.3). The rates were almost comparable for other regions, including Oceana (9.3), Asia (8.6), Latin America (8.2), and North America (8.2) [2,10]. The GLOBOCAN estimates suggested a higher ASMR for CRC in men (11.0) than women (7.2), with 515,637 and 419,536 deaths in men and women, respectively [2,10]. 2.2. Incidence CRC was reported as the third most common cancer worldwide (after breast and lung cancers) in 2020. The number of new cases of CRC was estimated to be 1,931,590 with an age-standardized incidence rate (ASR) of 19.5 per 100,000 person-years. The highest ASRs were estimated for Europe (30.4), followed by Oceana (29.8) and North America (26.2). After Asia (17.6) and Latin America (16.6), EMRO (9.1) and Africa (8.4) had the lowest ASRs for CRC (Figure 1). Hungary (45.3) and Guinea (3.3) had the highest and lowest ASRs for CRC among the other countries. The ASRs for CRC were almost four-fold higher in high-income (30.2) countries compared with low-income (8.8) and low–middle-income (7.4) countries. Similar discrepancies were reported in the incidence rates for CRC between countries with very high human development indices (HDIs) (29.4) and high HDIs (20.4) and those with medium HDIs (6.1) and low HDIs (7.4) [2,10]. This diversity may be explained by differences in exposure to CRC risk factors. We will discuss CRC risk factors in the next sections of this paper. [Figure: Estimated age-standardized incidence rate for colorectal cancer, 2020 (Data source: GLOBOCAN 2020; Map production: IARC, http://gco.iarc.fr/today, accessed on 10 October 2023).] 2.3. Time Trends and Future Burden There are discrepancies in the pattern of time trends in the incidence of CRC worldwide [1,6,11,12,13]. Considering the estimated annual percentage changes (EAPCs) in the ASRs for CRC during recent decades, constant or even slightly declining trends have been reported for formerly high-risk (transitioned) countries, including Denmark, Sweden, Australia, Canada, and the USA (Figure 2). In contrast, transitioning countries with relatively low-risk of CRC, including Brazil, Costa Rica, Colombia, Kuwait, and India, have shown increasing trends in the ASRs for CRC during the last decades (Figure 2) [1,11,14]. [Figure: Age-standardized incidence rates (ASRs) (per 100,000 person-years) in 2020 (A) and estimated annual percentage changes (EAPCs) in ASRs (B) for colorectal cancer in selected transitioned (Denmark, Australia, Canada, Sweden, USA) and transitioning (Brazil, Costa Rica, Colombia, Kuwait, India) countries (Source: GLOBOCAN 2020; Figure production, B: IARC, http://gco.iarc.fr/overtime, accessed on 23 March 2023) (* subnational data).] According to the GLOBOCAN 2020 estimates, the number of new cases of CRC will increase from 1,931,590 in 2020 to 3,154,674 in 2040, worldwide, suggesting a 63.3% increase in the number of new CRC cases. The greatest changes were estimated for currently low-risk population regions, including Africa (95.0%), EMRO (92.0%), Latin America (74.0%), and Asia (70.8%). The estimated changes in the number of new CRC cases are considerably lower in very-high-HDI countries (35.0%) compared to countries with low (10.2.6%), medium (72.1%), and high HDIs (67.9%) [3]. The increasing trends in the incidence rates for CRC in low-risk populations may be mainly explained by the increasing prevalence of risk